|
|
|
|
|
|
|
|
|
|
Rv2043c More about Rv2043c on TBDB.org More about Rv2043c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv2043c: Codons 130 to 134: 14 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Hirano K TLD 1997 | GTG/GGG | 389 | 130 | Val/Gly | 1997 | Canada | Sequencing | Whole gene | ZHRSE | >800 | Middlebrook 7H11 agar w/ pH of 6.0 | 33/168 | 1/0 | - | ![]() |
| Lee KW J Korean Med Sci 2001 | ins GG | 391 | - | Frameshift | 2001 | South korea | Sequencing | Whole gene | Z | - | PZase test with Wayne's method | 92/95 | 1/0 | - | ![]() |
| Lemaitre N AAC 1999 | ins GG | 391 | - | Frameshift | 1988 | France | Sequencing | Whole gene | ZHRES | 500-1000 | - | 19/35 | 1/0 | - | ![]() |
| Scorpio A AAC 1997 | del G | 391 | - | Frameshift | 1992-1995 | - | PCR-SSCP | Whole gene | Z | >900ug/ml | Pzase testing by Wayne's method | 46/46 | 1/0 | - | - |
| Lee KW J Korean Med Sci 2001 | ins G | 392 | - | Frameshift | 2001 | South korea | Sequencing | Whole gene | Z | - | PZase test with Wayne's method | 92/95 | 1/0 | - | - |
| Hirano K TLD 1997 | GGT/GAT | 395 | 132 | Gly/Asp | 1997 | Myanmar | Sequencing | Whole gene | Z | >800 | Proportion method | 33/168 | 1/0 | - | - |
| Scorpio A AAC 1997 | GGT/AGT | 394 | 132 | Gly/Ser | 1992-1995 | - | PCR-SSCP | Whole gene | Z | >900ug/ml | Pzase testing by Wayne's method | 46/46 | 2/0 | - | - |
| Hirano K TLD 1997 | del 16bp | 395-411 del | - | Frameshift | 1997 | India | Sequencing | Whole gene | ZR | >800 | Proportion method | 33/168 | 1/0 | - | - |
| Sreevatsan S AAC 1997 | ins T | 397 | - | Frameshift | 1996 | Diverse geographical locations | Sequencing | Whole gene | Z | - | BACTEC 460 | 67/118 | 1/0 | - | - |
| Marttila HJ AAC 1999 | ATT/ACT | 398 | 133 | Ile/Thr | 1994-1997 | Russia | Sequencing | Whole gene | Z | - | BACTEC 460 | 36/44 | 1/0 | not tested | - |
| Morlock GP AAC 2000 | ATT/AAT | 398 | 133 | Ile/Asn | 1999 | - | Sequencing | Whole gene | Z | 800 | Proportion method | 37/60 | 1/0 | - | - |
| Escalante P TuberLung Dis 1998 | GCC/GTC | 401 | 134 | Ala/Val | 1995-1996 | Peru | Sequencing | Whole gene | ZHRP | - | Proportion method | 40146 | 1/0 | "katG, 315, AGC/ACC; rpoB, 531, TCG/TTG; " | ![]() |
| Hou L Epi Infect 2000 | ins CC | 403 | - | Frameshift | 1996-1998 | China | PCR-SSCP | Whole gene | ZRE | 1000 | Proportion method, BACTEC 460 | 35/65 | 1/0 | - | - |
| Sreevatsan S AAC 1997 | ins C | 403 | - | Frameshift | 1996 | Diverse geographical locations | Sequencing | Whole gene | Z | - | BACTEC 460 | 67/118 | 1/0 | - | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |